Abstract：Objective To explore the application effect of Shenkang Injection in the treatment of Peritoneal dialysis patients.Methods A total of 40 patients with peritoneal dialysis treated in Huludao Central Hospital from October 2016 to October 2019 were selected and randomly divided into the control group (20 cases) and the study group (20 cases) by lottery,all the patients in the two groups were given peritoneal peritoneal dialysis treatment,on this basis,the patients in the study group were treated with Shenkang Injection.Both groups were treated for 4 weeks.The changes of indexes which included residual renal function,anaemia indexes,the levels of serum protein and the trace elements(calcium and phosphorus) were compared.Results After treatment 4 weeks,the glomerular filtration rate(GFR) of residual renal in the study group was higher than that in the control group,the anaemia indexes,the levels of protein and calcium in the study group were higher than those in the control group,the level of phosphorus in the study group was lower than that in the control group,the differences were statistically significant (P＜0.05);the reduces of residual renal function in the control group at treatment for 4 weeks was lower than that before treatment (P＜0.05).No obvious adverse reactions were observed in the two groups during the treatment.Conclusion Shenkang Injection is effective in the treatment of peritoneal dialysis,which can improve the residual function and nutritional status of patients,and it has good safety.
孔爱丽；仇晓玲. 肾康注射液在腹膜透析患者中的应用[J]. 中国当代医药, 2021, 28(4): 82-85.
KONG Ai-li ；QIU Xiao-ling. Application of Shenkang Injection in the treatment of peritoneal dialysis patients. 中国当代医药, 2021, 28(4): 82-85.
京公网安备 11010502046607号